how many ml of glutathione 30 Glutathione IV push - 1000mg

Description

Conjugation Technologies The successful design of ADCs in clinical settings relies not only on factors such as the potency and ratio of the payload, linker stability, and payload release but also on the choice of conjugation technologies

Frequently asked questions Have questions

WO2010095940A2 - Glutathione-based drug delivery system - Google Patents Glutathione-based drug delivery system Download PDF Info Publication number WO2010095940A2 WO2010095940A2 PCT/NL2010/050082 NL2010050082W WO2010095940A2 WO 2010095940 A2 WO2010095940 A2 WO 2010095940A2 NL 2010050082 W NL2010050082 W NL 2010050082W WO 2010095940 A2 WO2010095940 A2 WO 2010095940A2 Authority WO WIPO (PCT) Prior art keywords agent gsh glutathione ligand drug Prior art date Legal status (The legal status is an assumption and is not a legal conclusion